Medical News

RSS

Cubist Pharmaceuticals reports total revenues for fourth-quarter and full-year 2009

Cubist Pharmaceuticals, Inc. today announced total revenues for both the fourth quarter and full year ended December 31, 2009.

11 Jan 2010

Exercise may improve cognitive function

Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition, according to two reports in the January issue of Archives of Neurology, one of the JAMA/Archives journals.

11 Jan 2010

State Radio in China to launch HIV/AIDS educational program

China National Radio (CNR) on Jan. 16 is set to air a weekly one-hour program aimed at increasing HIV/AIDS awareness, Xinhua reports. People living with HIV will help co-host the program - "Positive Talks" - which will feature communication between hosts and the audience as well as experts on HIV/AIDS prevention and more, Yang Wenyan, deputy editor-in-chief of CNR, said Saturday.

11 Jan 2010

Targacept signs collaboration and license agreement with AstraZeneca

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

11 Jan 2010

Coalition will respond to IOM report on viral hepatitis and support CDC research and programs

In anticipation of the release of the Institute of Medicine (IOM) report on viral hepatitis, the CDC Foundation (the independent nonprofit partner of the Centers for Disease Control and Prevention), in partnership with CDC's Division of Viral Hepatitis, recently launched the Viral Hepatitis Action Coalition.

11 Jan 2010

CMS study finds Senate health bill would increase costs less steeply than thought

A report from the Center on Medicare and Medicaid Services finds that the Senate health bill would increase health care spending less steeply than previously thought.

11 Jan 2010

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate. These clinical trials are designed to demonstrate that AMR101 lowers triglyceride levels in patients with very high triglycerides (the MARINE Study) and high triglycerides in patients with mixed dyslipidemia being treated with statins (the ANCHOR Study).

11 Jan 2010

New data from phase 3 study of avanafil for treatment of ED announced

VIVUS, Inc. today announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED).

11 Jan 2010

Albertsons launches new online community to provide value-driven choices for healthier living

Albertsons, a SUPERVALU company, today launched a new online community, AlbertsonsWellbeing.com, that will provide users with tools to help them make easy, value-driven choices for healthier living.

11 Jan 2010

A wellness provision in the Senate reform bill draws opposition

A health overhaul provision meant to encourage healthier lifestyles by allowing companies to give insurance discounts to workers who meet certain milestones has found unlikely opposition, The (Wilmington, Del.,) News Journal reports.

11 Jan 2010

NIH renews grant to continue cell growth regulation research

The new year began on a high note for Alan Leonard and Julia Grimwade, professors of biological sciences at Florida Institute of Technology, when they learned their National Institutes of Health grant, which they have held for the last 11 years, had been renewed for four more years. The competitive renewal brings them $1,024, 944 to continue their research into the regulation of cell growth and division.

11 Jan 2010

Wall Street Journal examines polio vaccinations in Afghanistan

In a story about polio vaccination campaigns in Afghanistan, the Wall Street Journal examines how the Taliban and international health agencies are working together to promote oral vaccination campaigns across the country.

11 Jan 2010

Uphill battles for lawmakers as intensity picks up on health bill negotiations

Politico: "Speaker Nancy Pelosi is telling her caucus not to believe stories that the House will simply roll over and accept the Senate's hard-fought health care bill." But as Senate Majority Leader Harry Reid is tasked with holding together his 60 votes to pass reform, Pelosi "may not have a choice."

11 Jan 2010

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that it has received $3.75 million in milestone payments from partner Galderma S.A.

11 Jan 2010

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

11 Jan 2010

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.

11 Jan 2010

First Edition: January 11, 2010

Today's headlines highlight Democrats' ongoing efforts to blend the House- and Senate-passed versions of health reform and Republican's continuing efforts to criticize the legislation.

11 Jan 2010

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts announced today that Catholic Health Initiatives (CHI) has selected the Allscripts Electronic Health Record (EHR) solution for its 1050 employed physicians to enhance the quality of patient care, improve communications, and deliver more cost-effective care.

11 Jan 2010

Allscripts introduces Allscripts Stimulus Program for physicians

Allscripts today introduced the Allscripts Stimulus Program, making it safe and easy for physicians to purchase and rapidly deploy Electronic Health Records that will qualify for significant federal incentives.

11 Jan 2010

Patient News Publishing and Eco-Dentistry Association to offer premium dental newsletters

Patient News Publishing, a leading dental marketing company, is proud to announce they have teamed with the Eco-Dentistry Association to bring new articles to Patient News Publishing's dental advertising newsletter clients.

11 Jan 2010

Medical News

Cubist Pharmaceuticals reports total revenues for fourth-quarter and full-year 2009

Exercise may improve cognitive function

State Radio in China to launch HIV/AIDS educational program

Targacept signs collaboration and license agreement with AstraZeneca

Coalition will respond to IOM report on viral hepatitis and support CDC research and programs

CMS study finds Senate health bill would increase costs less steeply than thought

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

New data from phase 3 study of avanafil for treatment of ED announced

Albertsons launches new online community to provide value-driven choices for healthier living

A wellness provision in the Senate reform bill draws opposition

NIH renews grant to continue cell growth regulation research

Wall Street Journal examines polio vaccinations in Afghanistan

Uphill battles for lawmakers as intensity picks up on health bill negotiations

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Lives of 400 Swedes can be saved annually if side effects of pharmaceuticals prevented

First Edition: January 11, 2010

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts introduces Allscripts Stimulus Program for physicians

Patient News Publishing and Eco-Dentistry Association to offer premium dental newsletters

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News